신 이식 9년 후 발생한 폐포자충 폐렴 1예 = Late Onset Infection of Pneumocystis jirovecii Infection in a Renal Transplant Recipient

다국어 초록 (Multilingual Abstract)

Pneumocystis jirovecii pneumonia (PCP) can be a life-threatening opportunistic infection after kidney transplantation, occurring most frequently in the first 12 months with the symptoms of dyspnea, cough, fever, and hypoxia. Prophylaxis for PCP is usually applied during the first 3 months to 1 year after transplantation, but late onset incidence of PCP can be detected. We report on a patient who developed PCP 9 years after renal transplantation. The patient showed indolent onset of acute respiratory distress and was treated with trimethoprim-sulfamethoxazole and corticosteroid therapy. Previous rescue treatment of acute cellular rejection with ongoing maintenance of an elevated level of immunosuppressants may have predisposed the patient to PCP.

참고문헌 (Reference)

1 Struijk GH, "Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation" 26 : 3391-3398, 2011

2 Eitner F, "Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients" 26 : 2013-2017, 2011

3 Radisic M, "Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study" 5 : 84-93, 2003

4 Arend SM, "Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients" 22 : 920-925, 1996

5 Thomas CF Jr, "Pneumocystis pneumonia" 350 : 2487-2498, 2004

6 De Castro N, "Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis:a case-control study" 16 : 1375-1377, 2010

7 Yazaki H, "Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host" 88 : 380-385, 2009

8 Sepkowitz KA, "Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome" 34 : 1098-1107, 2002

9 Walzer PD, "Mandell, Douglas, and Bennett’s principles and practice of infectious diseases" Churchill Livingstone/Elsevier 3377-3390, 2010

10 Kidney Disease: Improving Global Outcomes (KDIGO)Transplant Work Group, "KDIGO clinical practice guideline for the care of kidney transplant recipients" 9 (9): S1-S155, 2009

11 Alangaden GJ, "Infectious complications after kidney transplantation: current epidemiology and associated risk factors" 20 : 401-409, 2006

12 Fishman JA, "Infection in organ-transplant recipients" 338 : 1741-1751, 1998

13 Lufft V, "Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression" 62 : 421-423, 1996

14 Torres J, "Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: a blinded comparison to standard methods" 30 : 141-145, 2000

15 Flori P, "Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens" 53 (53): 603-607, 2004

16 Neff RT, "Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia" 88 : 135-141, 2009